240 related articles for article (PubMed ID: 5114186)
1. Therapeutic guidelines and side effects encountered during L-dopa therapy in 100 cases of parkinsonism.
Jenkins AC; Schwieger AC
Med J Aust; 1971 Oct; 2(14):693-700. PubMed ID: 5114186
[No Abstract] [Full Text] [Related]
2. Therapeutic uses and side effects of L-dopa.
Boshes B
Adv Intern Med; 1972; 18():219-49. PubMed ID: 4576081
[No Abstract] [Full Text] [Related]
3. [Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].
Tissot R; Gaillard JM; Guggisberg M; Gauthier G; de Ajuriaguerra J
Presse Med (1893); 1969 Apr; 77(17):619-22. PubMed ID: 5785081
[No Abstract] [Full Text] [Related]
4. [Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor].
Guillard A
Brux Med; 1972 Oct; 52(10):673-80. PubMed ID: 4656191
[No Abstract] [Full Text] [Related]
5. Treatment of parkinsonism with levo-dopa: results in 302 cases.
Newkirk TA; Magee KR
Mich Med; 1971 Sep; 70(22):805-11. PubMed ID: 5141211
[No Abstract] [Full Text] [Related]
6. [Indications and results of monoamine treatment in parkinsonian syndromes].
Boudin G; Pépin B; Guillard A; Fabiani JM; Haguenau M
Rev Neurol (Paris); 1972 Jul; 127(1):79-97. PubMed ID: 4520464
[No Abstract] [Full Text] [Related]
7. [Collateral effects of L-dopa treatment in patients with parkinsonism].
Signorelli CD; D'Andrea F; De Divitiis E
Sist Nerv; 1970; 22(2):109-14. PubMed ID: 5504548
[No Abstract] [Full Text] [Related]
8. [Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].
Schneider E; Fischer PA; Jacobi P; Maxion H
Arch Psychiatr Nervenkr (1970); 1973 Mar; 217(1):95-112. PubMed ID: 4695662
[No Abstract] [Full Text] [Related]
9. [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].
Ferel D
Schweiz Med Wochenschr; 1972 Jan; 102(3):88-94. PubMed ID: 4551909
[No Abstract] [Full Text] [Related]
10. [Collateral effects of therapy with L-dopa in Parkinson's disease].
Gomirato G; Perfetti CC; Ecari U
Sist Nerv; 1970; 22(2):67-73. PubMed ID: 5504559
[No Abstract] [Full Text] [Related]
11. [Treatment of Parkinson's disease with L-dopa combined with a decarboxylase inhibitor].
Siegfried J; Klaiber R; Perret E; Ziegler WH
Dtsch Med Wochenschr; 1969 Dec; 94(52):2678-81. PubMed ID: 4903342
[No Abstract] [Full Text] [Related]
12. [Dopamine and abnormal movements].
Rondot P; Dumas RJ
Rev Neurol (Paris); 1972 Jul; 127(1):99-113. PubMed ID: 4272134
[No Abstract] [Full Text] [Related]
13. [Clinical study of L-dopa in Parkinson's disease].
Franken L; Noel G; Lhoas JP; Meyers C; Noel P; Ectors M
Brux Med; 1972 Dec; 52(12):851-60. PubMed ID: 4575350
[No Abstract] [Full Text] [Related]
14. [Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].
Court J; Kase JC; Mena I; Palacios E
Rev Med Chil; 1973 Jun; 101(6):452-5. PubMed ID: 4764560
[No Abstract] [Full Text] [Related]
15. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
Andrews CJ; Somerville B
Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384
[No Abstract] [Full Text] [Related]
16. [Clinical studies on the treatment of parkinsonism with the L-dopa and decarboxylase inhibitor Ro-4-4602 association].
Wajsbort J; Hemli JA; Alfandary I; Yahel M; Siegfried J
Wien Med Wochenschr; 1971 Oct; 121(42):741-5. PubMed ID: 5115985
[No Abstract] [Full Text] [Related]
17. [Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)].
Steinhäusl H
Wien Med Wochenschr; 1973 Jun; 123(26):433-5. PubMed ID: 4578743
[No Abstract] [Full Text] [Related]
18. [Treatment of Parkinson's disease with L-dopa. 77 cases].
Boudin G; Castaigne P; Lhermitte F; Beck H; Guillard A; Marteau R; Pepin B; Rondot P; Raphy B
Rev Neurol (Paris); 1970 Feb; 122(2):89-102. PubMed ID: 4931719
[No Abstract] [Full Text] [Related]
19. [Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study].
Tissot R; de Ajuriaguerra J
Nouv Presse Med; 1973 Feb; 2(5):315-6. PubMed ID: 4686226
[No Abstract] [Full Text] [Related]
20. [Treatment of parkinsonism with L-dopa and an L-aromatic amino acid inhibitor].
Streifler M; Vardi J; Kesten M
Harefuah; 1972 Nov; 83(9):362-4. PubMed ID: 4669737
[No Abstract] [Full Text] [Related]
[Next] [New Search]
